101 Therapeutics
101 Therapeutics is a clinical stage pharma company curing infectious diseases by targeting the pathology not the the pathogen.
101 Therapeutics is a business in biopharma, biotechnology, life science, medical, pharmaceutical, therapeutics based in Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA), founded in 2020.
Within the biopharma, biotechnology, life science, medical, pharmaceutical, therapeutics space, the company focuses on its core offering rather than a broad product line.
Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA) is where the company is located.
Its current recorded stage is Series_A.
Its team size is recorded as c_00001_00010 employees.
Public records show total funding of about $15M.
| Sector | Biopharma, Biotechnology, Life Science, Medical, Pharmaceutical, Therapeutics |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA) |
| Country | IL |
| Founded | 2020 |
| Employees | c_00001_00010 |
| Stage | series_a |
| Total funding | $15,000,000 |
Website: 101therapeutics.com
Browse related
Create a free account